Dentists in Oakbrook, IL Accepting Medicare
3 Dentists found. Showing 1 - 3
 Dr. James B Chidester Sr., DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 120 Oakbrook Center Mall, Ste 510, Oakbrook, IL 60523 Phone: 630-571-0393 Fax: 630-571-4510 |
Raul Tony Aleman Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 120 Oakbrook Center Mall, Ste # 802, Oakbrook, IL 60523 Phone: 630-571-3030 Fax: 630-571-1977 |
Joseph G Arredondo, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 120 Oakbrook Center Mall, Ste 802, Oakbrook, IL 60523 Phone: 630-571-3030 Fax: 630-571-1977 |
News Archive
New Clinical Practice Guideline for evaluation and treatment of pituitary incidentalomas
Today, The Endocrine Society released a new Clinical Practice Guideline (CPG) for the evaluation and treatment of pituitary incidentalomas. The CPG is published in the April 2011 issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.
Calif. enrollment campaign focused on exchange at expense of Medicaid backlog
The California Health Report examines how the state's efforts prioritized the marketplace issues but fell short in handling Medicaid enrollment. In other Medicaid expansion news, the Arkansas director announces he's leaving and Maine's legislature cannot override the governor's veto.
China PharmaHub and Chengdu Yongkon Pharmacy sign cooperation agreement
China PharmaHub Corp., recently merged with World Wide Relics, which will be shortly changing its name to China PharmaHub Corp, is proud to announce it has signed a cooperation agreement with Chengdu Yongkon Pharmacy Co. Ltd., a pharmaceutical company based in Sichuan, with an established sales network of over 2600 hospitals in China.
Black women at less risk of fractures
A recent report from the U.S. surgeon general on bone health and osteoporosis has found that black women have a lower risk of fracture than white women at every level of bone mineral density.
CytRx's aldoxorubicin receives European orphan medicinal product designation for treatment of advanced soft tissue sarcomas
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that aldoxorubicin has received orphan medicinal product designation from the European Commission for the treatment of advanced soft tissue sarcomas. The designation is to encourage the development of drugs which may provide significant benefit to patients suffering from rare diseases.
› Verified 2 days ago